Snowden Capital Advisors’s Immunocore IMCR Stock Holding History

Snowden Capital Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$224K	Buy	7,430 +460	+7%	+$14.9K	0.01%	1164
2025 Q4	$242K	Sell	6,970 -578	-8%	-$20.4K	0.01%	1137
2025 Q3	$274K	Sell	7,548 -126	-2%	-$4.28K	0.01%	1055
2025 Q2	$241K	Buy	7,674 +198	+3%	+$6.15K	0.01%	1100
2025 Q1	$222K	Sell	7,476 -197	-3%	-$5.91K	0.01%	1118
2024 Q4	$226K	Sell	7,673 -138	-2%	-$4.36K	0.01%	1110
2024 Q3	$243K	Buy	7,811 +179	+2%	+$6.51K	0.01%	1105
2024 Q2	$259K	Buy	7,632 +137	+2%	+$6.99K	0.01%	1027
2024 Q1	$487K	Sell	7,495 -42	-0.6%	-$2.88K	0.02%	774
2023 Q4	$515K	Buy	7,537 +289	+4%	+$15K	0.02%	682
2023 Q3	$376K	Buy	7,248 +1,729	+31%	+$102K	0.02%	775
2023 Q2	$331K	Buy	+5,519	New	+$315K	0.01%	918

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Snowden Capital Advisors's IMCR Position: Q1 2026 in Review

Snowden Capital Advisors increased its Immunocore (IMCR) stake by 6.6% in Q1 2026, buying an estimated $14.9K and bringing the position to 7,430 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #1164.

Snowden Capital Advisors first reported a position in IMCR in Q2 2023 and has held it in 12 quarters since. The position peaked at $515K in Q4 2023. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Snowden Capital Advisors held 7,430 shares of Immunocore worth $224K as of Q1 2026.
Snowden Capital Advisors bought 460 Immunocore shares in Q1 2026, an estimated $14.9K.
Immunocore made up 0.01% of Snowden Capital Advisors's portfolio in Q1 2026, its #1164 holding.
Snowden Capital Advisors first reported a position in Immunocore in Q2 2023 and has held it in 12 quarters since.
Snowden Capital Advisors's Immunocore position peaked at $515K in Q4 2023.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.